Published in Am J Physiol on October 01, 1974
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999) 3.38
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation (2001) 2.34
Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation (1996) 2.20
Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Eur Heart J (2001) 2.06
A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and Kelly's-M1 steroid: clinical and morphological findings. J Clin Endocrinol Metab (1995) 2.01
Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation (1998) 1.95
Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol (1997) 1.84
Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation (1996) 1.75
Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol (1998) 1.73
Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation (1995) 1.66
Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv (2000) 1.65
Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation (1998) 1.63
Vessel size and long-term outcome after coronary stent placement. Circulation (1998) 1.61
Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation. Circulation (2001) 1.61
Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med (2008) 1.60
PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol (2000) 1.56
Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation (2000) 1.56
Operator volume and outcome of patients undergoing coronary stent placement. J Am Coll Cardiol (1998) 1.56
Dissociation between coronary sinus and left atrial conduction in patients with atrial fibrillation and flutter. J Cardiovasc Electrophysiol (2001) 1.56
Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol (2001) 1.55
A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J (1997) 1.53
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy. J Thromb Haemost (2010) 1.52
Comparison of angiography and intravascular ultrasound for the assessment of lumen size after coronary stent placement: impact of dilation pressures. Cathet Cardiovasc Diagn (1997) 1.49
Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation (1997) 1.47
Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis. Thromb Haemost (2012) 1.45
Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. Circulation (2000) 1.45
Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel. J Thromb Haemost (2006) 1.43
A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. J Intern Med (2004) 1.43
Gene transfer of heterologous G protein-coupled receptors to cardiomyocytes: differential effects on contractility. Circ Res (2001) 1.42
G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis (2000) 1.39
Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol (1996) 1.38
Distribution of angiographic measures of restenosis after drug-eluting stent implantation. Heart (2009) 1.38
Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography. J Am Coll Cardiol (1999) 1.38
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release. Circ Res (1984) 1.38
Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis (2001) 1.36
Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther (1986) 1.32
Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol (1999) 1.25
Restenosis after coronary placement of various stent types. Am J Cardiol (2001) 1.24
Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res (1987) 1.23
Early prediction of outcome in head-injured patients. J Neurosurg (1981) 1.22
Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol (1997) 1.21
Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Ann Surg (1989) 1.17
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost (2009) 1.17
Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA (2000) 1.16
Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart (2001) 1.16
Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther (2001) 1.15
Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res (1980) 1.15
Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting. J Am Coll Cardiol (1996) 1.14
Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis (2000) 1.13
Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. Pacing Clin Electrophysiol (1997) 1.13
Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system. Am J Cardiol (2001) 1.12
Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol (1980) 1.10
Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg (1983) 1.07
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest (2008) 1.07
Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension. Circ Res (1978) 1.07
Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood (2000) 1.06
Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation (1997) 1.06
Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol (2000) 1.06
Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. Heart (1996) 1.05
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. Blood (2001) 1.05
Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacologic stress testing: a comparison with stress echocardiography and perfusion scintigraphy. J Am Coll Cardiol (2000) 1.04
Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol (2000) 1.04
Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol (1977) 1.04
Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol (1997) 1.03
Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats? Lancet (1976) 1.02
Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation (1998) 1.01
Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation (1998) 1.01
Time course of restenosis during the first year after emergency coronary stenting. Circulation (1993) 1.01
Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol (1999) 1.01
Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions. Circulation (1998) 1.01
The effect of nutritional support on outcome from severe head injury. J Neurosurg (1987) 1.00
Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol (1996) 0.99
New aspects in ultrasound-guided compression repair of postcatheterization femoral artery injuries. Circulation (1994) 0.99
Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. Circulation (1996) 0.98
Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. Circ Res (1987) 0.98
Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal Ed (1999) 0.98
Management of 219 consecutive cases of postcatheterization pseudoaneurysm. J Am Coll Cardiol (1997) 0.98
Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation. Circulation (1999) 0.98
Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B. J Cardiovasc Electrophysiol (1997) 0.97
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation. Circ Res (1984) 0.97
Salt and water balance and renin activity in renal hypertension of rats. Am J Physiol (1975) 0.96
Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol (1976) 0.96
alpha-Thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors. Am J Physiol (1999) 0.95
Potassium deficiency in rats with hereditary diabetes insipidus. Am J Physiol (1974) 0.95
Diagnosis of rotator cuff lesions: comparison of US and MRI on 38 joint specimens. Eur Radiol (1997) 0.95
Recovery of myocardial perfusion in acute myocardial infarction after successful balloon angioplasty and stent placement in the infarct-related coronary artery. J Am Coll Cardiol (1997) 0.95